Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry

Abstract
No abstract available
Funding Information
  • Yonsei University College of Medicine (6-2010-0040)
  • Brain Korea 21 Project for Medical Science
  • Yonsei University
  • Novartis Korea Co
  • Astra Zeneca Korea Co
  • Dong-A Pharmaceutical Co
  • Sanofi-Aventis Pharmaceutical Co

This publication has 30 references indexed in Scilit: